RXRX News and Press, Recursion Pharmaceuticals Inc.

2024-06-28 10:28:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Searching for quality undiscovered biotech stocks can be a bit like a treasure hunt. The biotech scene is full of intriguing innovators trying to progress their treatments through various c...

2024-06-27 08:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week, Nvidia (NASDAQ: NVDA ) briefly eclipsed Microsoft (NASDAQ: MSFT ) as the world’s most valuable company. The AI chip maker is now worth $3.3 trillion&#x...

2024-06-27 04:17:52 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals: More Of A TechBio Industrializing Drug Discovery Recursion Pharmaceuticals: Unprecedented Scale Recursion Pharmaceuticals: Catalysts Are Coming And Success Is A Must AI-discov...

Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...

2024-06-26 16:27:54 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals: More Of A TechBio Industrializing Drug Discovery Recursion Pharmaceuticals: Unprecedented Scale Recursion Pharmaceuticals: Catalysts Are Coming And Success Is A Must AI-discov...

Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that it intends to offer and sell $200.0 million of shares...

Recursion delivered multiple data packages to Bayer and initiated the first joint oncology project, which is now expected to advance rapidly towards Lead Series nomination Bayer to become first external beta-user of LOWE (LLM-Orchestrated Workflow Engine) for drug discovery and development ...

2024-06-24 03:36:09 ET Summary This thesis makes the case for an investment in Recursion Pharmaceuticals operating as a TechBio which "industrializes" the process of drug discovery in contrast to a typical biotech. The difference between TechBio and biotech may appear subtle, but ...

2024-06-17 10:53:46 ET Summary Recursion Pharmaceuticals is an AI-enabled drug discovery company, differentiated by its scale and focus on understanding biology. The company has a broad pipeline across various therapeutic areas and strategic partnerships with biopharmaceutical com...

2024-06-14 13:28:07 ET Summary Recursion Pharma is an AI-driven drug developer that boasts supercomputers designed to shorten drug development timelines and enhance successful outcomes. Many such companies have raised substantial sums from private equity and hedge funds but few ha...